Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
Author:
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference5 articles.
1. Allogeneic hematopoietic cell transplantation vs standard consolidation chemotherapy in patients with intermediate-risk acute myeloid leukemia: a randomized clinical trial;Bornhäuser;JAMA Oncol.,2023
2. DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant;Dillon;JAMA,2023
3. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia;Venditti;Blood,2019
4. Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission;Jentzsch;Blood Adv.,2022
5. Myeloablative haploidentical transplantation is superior to chemotherapy for patients with intermediate-risk acute myelogenous leukemia in first complete remission;Lv;Clin. Cancer Res.,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Sustainable Battery Technologies: Enhancing Longevity, Recycling, and Alternative Components-- A Review;American Journal of Applied Chemistry;2024-08-27
2. Single-cell immune landscape of measurable residual disease in acute myeloid leukemia;Science China Life Sciences;2024-07-19
3. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation;Virology Journal;2024-05-14
4. Allogeneic haematopoietic stem cell transplantation for adult T‐lymphoblastic lymphoma: A real‐world multicentre analysis in China;British Journal of Haematology;2024-04-25
5. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment;Frontiers in Oncology;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3